| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 11/12/2009 | US20090280090 Methods of treating pigs with bacillus strains |
| 11/12/2009 | US20090280086 Methods and compositions for treating hepatitis c virus |
| 11/12/2009 | US20090280084 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| 11/12/2009 | US20090280083 Compounds for the Treatment of Hepatitis C |
| 11/12/2009 | CA2725227A1 Antiviral cell penetrating peptides |
| 11/12/2009 | CA2723683A1 7h-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c |
| 11/12/2009 | CA2723564A1 Sialic acid to support the immune system in the elderly |
| 11/12/2009 | CA2723232A1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases |
| 11/12/2009 | CA2723080A1 Heterocyclic antiviral compounds |
| 11/12/2009 | CA2717119A1 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
| 11/12/2009 | CA2712586A1 Antibacterial fluoroquinolone analogs |
| 11/11/2009 | EP2116603A2 Antimicrobial peptides |
| 11/11/2009 | EP2116552A2 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient |
| 11/11/2009 | EP2116532A1 Azapeptide derivatives as HIV protease inhibitors |
| 11/11/2009 | EP2116524A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid |
| 11/11/2009 | EP2116263A1 Reversibly light-switchable drug-conjugates |
| 11/11/2009 | EP2116253A1 Novel phyllanthus extract |
| 11/11/2009 | EP2116243A1 Gel composition for treating mycosis |
| 11/11/2009 | EP2116140A1 Sialic acid to support the immune system in the elderly |
| 11/11/2009 | EP2115164A2 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 11/11/2009 | EP2115140A1 Positively charged water-soluble prodrugs of 1h-imidazo [4, 5-c] quinolin-4-amines and related compounds with very high skin penetration rates |
| 11/11/2009 | EP2114980A2 Antiviral nucleoside analogs |
| 11/11/2009 | EP2114904A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same |
| 11/11/2009 | EP2114902A2 Hiv inhibiting 5,6-substituted pyrimidines |
| 11/11/2009 | EP2114901A1 Hiv inhibiting 6-substituted pyrimidines |
| 11/11/2009 | EP2114900A1 Thiopyrimidine-based compounds and uses thereof |
| 11/11/2009 | EP2114460A2 Methods and compositions for the disruption of biofilms |
| 11/11/2009 | EP2114442A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 11/11/2009 | EP2114406A1 Thioxanthene derivates usefulto treat infectious diseases |
| 11/11/2009 | EP2114400A2 Use of riluzole and derivatives thereof for producing new drugs |
| 11/11/2009 | EP2114395A2 Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof |
| 11/11/2009 | EP1818052B1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 11/11/2009 | EP1765360B1 Anti-viral uses of borinic acid complexes |
| 11/11/2009 | EP1742908B1 Non-nucleoside reverse transcriptase inhibitors |
| 11/11/2009 | EP1713823B1 Hcv ns-3 serine protease inhibitors |
| 11/11/2009 | EP1537104B1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 11/11/2009 | EP1519960B1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 11/11/2009 | EP1513551B1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 11/11/2009 | EP1482795B1 New immunoeffector compounds |
| 11/11/2009 | EP1450856B1 Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use |
| 11/11/2009 | EP1372634B1 Use of fumaric acid amides |
| 11/11/2009 | EP1181314B1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations |
| 11/11/2009 | CN101578368A Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 11/11/2009 | CN101578294A Inhibitors of hepatitis C virus |
| 11/11/2009 | CN101578108A Salmonella vaccine in poultry |
| 11/11/2009 | CN101578103A Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 11/11/2009 | CN101575608A Recombinant combined DNA vaccine aiming to avian influenza virus |
| 11/11/2009 | CN101575593A Vaccine for hand-foot-mouth disease and preparation method and application thereof |
| 11/11/2009 | CN101575592A Virulent phage sensitive to riemerella anatipestifer and application thereof |
| 11/11/2009 | CN101575589A Abortus Brucella vaccine strain S19 marked recombinant strain and application thereof |
| 11/11/2009 | CN101575587A Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine |
| 11/11/2009 | CN101575586A Bordetella bronchiseptica gene deleted vaccine and application |
| 11/11/2009 | CN101575365A Antiviral protein and preparation method and application thereof |
| 11/11/2009 | CN101575364A Fresh water fish bacterial gill-rot disease inactivated vaccine |
| 11/11/2009 | CN101575361A Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
| 11/11/2009 | CN101575346A Process for preparing cefsulodin sodium |
| 11/11/2009 | CN101575345A Method for removing residual palladium in crude product of faropenem sodium prepared by palladium catalysis method |
| 11/11/2009 | CN101575344A Method for preparing high-purity pseudo-polymorphic lavo-ofloxacin hemihydrate |
| 11/11/2009 | CN101575339A 8-hydroxypyrimido-[3,2-d]pyrimidine-7-carboxylic acid derivatives having anti-HIV activity, preparation method thereof and use thereof |
| 11/11/2009 | CN101575330A Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof |
| 11/11/2009 | CN101575320A Water-soluble triazole antifungal compound |
| 11/11/2009 | CN101575318A Novel dihydropyridine compound and application thereof on preparing drugs for curing and/or preventing virus diseases |
| 11/11/2009 | CN101575314A Dihydropyridine compounds and application thereof on preparing drugs for curing and/or preventing virus diseases |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574516A Triple vaccine of bacterial gill-rot, sepsis and red-skin diseases of grass carps and preparation method thereof |
| 11/11/2009 | CN101574515A Application of Lambda interferon in resisting human immunodeficiency virus |
| 11/11/2009 | CN101574508A Traditional Chinese medicine for treating flu in swinery |
| 11/11/2009 | CN101574494A Drug for treating hepatitis B |
| 11/11/2009 | CN101574488A Chinese medicament for treating urinary tract infection |
| 11/11/2009 | CN101574487A Chinese medicament for treating chronic stranguria |
| 11/11/2009 | CN101574486A Quality control method for Chinese medicinal capsule for treating anemofrigid cold |
| 11/11/2009 | CN101574469A Traditional Chinese medicine for treating passionate type swine plague |
| 11/11/2009 | CN101574442A Externally applied Chinese medicament for treating herpes zoster |
| 11/11/2009 | CN101574421A Medicament for treating leukemia and septicemia |
| 11/11/2009 | CN101574407A Drug for preventing cold and preparation method thereof |
| 11/11/2009 | CN101574383A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginoside |
| 11/11/2009 | CN101574381A Extractive of effective part of chloranthus glaber and preparation method thereof |
| 11/11/2009 | CN101574356A Tenofovir disoproxil pharmaceutical salt and preparations thereof |
| 11/11/2009 | CN101574355A Compound antibacterial injection for livestock and preparation method thereof |
| 11/11/2009 | CN101574354A Onychomycosis ointment and preparation method thereof |
| 11/11/2009 | CN101574351A Cefmetazole preparation used for injection and preparation method thereof |
| 11/11/2009 | CN101574333A Allitride composition and method for preparing drop therewith for treating nasal cavity infected by microbes and application thereof |
| 11/11/2009 | CN101574321A Ketoconazole vaginal tablet and preparation method thereof |
| 11/11/2009 | CN101574319A Podophyllotoxin vesicle and preparation method thereof |
| 11/11/2009 | CN101574094A New preparation technology and new applications of syringa amurensis rupr bar extract components |
| 11/11/2009 | CN101574093A New preparation technology and new applications of syringa amurensis rupr bar volatile oil |
| 11/11/2009 | CN100558715C Protein kinase inhibitors |
| 11/11/2009 | CN100558685C Extract from the pods of lupin seeds containing lupeol |
| 11/11/2009 | CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/11/2009 | CN100558403C Double-shell medicine sustained and controlled releasing carrier material and preparation method and application thereof |
| 11/11/2009 | CN100558401C Adjuvant systems and vaccines |
| 11/11/2009 | CN100558395C Hybrid peptide modulate immune response |
| 11/11/2009 | CN100558383C Traditional Chinese medicine used for treating human papillomavirus infection |
| 11/11/2009 | CN100558376C Capsicum ethylsine tablet preparation and its preparation method |
| 11/11/2009 | CN100558373C Chinese pharmaceutical compositions for treating epidemic cerebrospinal meningitis and processes for preparation thereof |
| 11/11/2009 | CN100558369C Therapeutical treatments |
| 11/11/2009 | CN100558363C Medicinal composition for treating moist wart |
| 11/11/2009 | CN100558357C Medicine composition for treating mixed infectious disease |
| 11/11/2009 | CN100558348C Sallowness preparation, its making method and quality control |
| 11/10/2009 | US7615635 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics |